Scancell Holdings Plc
1 known investors
Scancell is a late-stage clinical biotechnology company developing active immunotherapies to strengthen anti-tumor immune responses in hard-to-treat cancers. Its treatments are built on its proprietary Immunobody and Moditope platforms.
Founders & leadership
PL
Professor Lindy DurrantCo-founder & Chief Scientific Officer
PL
Phil L'HuillierChief Executive Officer
DS
David SchilanskyInterim Chief Financial Officer
DN
Dr Nermeen VarawallaChief Medical Officer
Board
DJ
Dr Jean-Michel CosséryNon-Executive Chairman
Investors · 1
Frequently asked questions
- What does Scancell Holdings Plc do?
- Scancell is a late-stage clinical biotechnology company developing active immunotherapies to strengthen anti-tumor immune responses in hard-to-treat cancers. Its treatments are built on its proprietary Immunobody and Moditope platforms.
- Who founded Scancell Holdings Plc?
- Scancell Holdings Plc was founded by Professor Lindy Durrant.
- Who are Scancell Holdings Plc's investors?
- Scancell Holdings Plc's investors include Seneca Partners.